Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms

BACKGROUND: Tuberculosis is a leading cause of infectious disease‐related death and is one of the top 10 causes of death worldwide. The World Health Organization (WHO) recommends the use of specific rapid molecular tests, including Xpert MTB/RIF or Xpert Ultra, as initial diagnostic tests for the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Adrienne E, Ross, Jennifer M, Yao, Mandy, Schiller, Ian, Kohli, Mikashmi, Dendukuri, Nandini, Steingart, Karen R, Horne, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437892/
https://www.ncbi.nlm.nih.gov/pubmed/33755189
http://dx.doi.org/10.1002/14651858.CD013694.pub2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437892/
https://www.ncbi.nlm.nih.gov/pubmed/33755189
http://dx.doi.org/10.1002/14651858.CD013694.pub2

Ejemplares similares